Pnoe
PNOĒ builds portable clinical-grade breath analysis devices and software that measure 23 metabolic biomarkers (VO2 max, RMR, biological age) for health professionals. Founded 2016, it serves 3,000+ practitioners across functional medicine, fitness, longevity, and hospitality segments.
- Company typePrivate
- Founded2016
- HeadquartersMalden, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pnoe does
PNOĒ (legal entity: PNOĒ Inc.) is a US-based health technology company founded in 2016 that builds and sells portable breath analysis devices for clinical-grade metabolic testing. The company is headquartered in Malden, Massachusetts, with an EU representative entity (XHALE S.A.) in Kifissia, Greece. The core product is the PNOĒ device — a portable indirect calorimetry system measuring both oxygen consumption (VO2) and carbon dioxide production (VCO2) to derive 23 metabolic biomarkers, including VO2 max, resting metabolic rate (RMR), fat and carbohydrate oxidation, ventilatory efficiency, heart rate variability, and biological age. The device is validated against the COSMED Quark CPET clinical gold standard and completes testing in under 10 minutes without blood draws or lab work.
The product ecosystem extends beyond hardware into software. Breath data flows from the device through the PNOĒ Precision App (iOS mobile application integrating Apple Health and Google Fit) into the PNOĒ Health Dashboard, a cloud-based platform that unifies 225+ biomarkers from wearables, blood tests, and body scans. Additional modules include the Nutrition & Training Builder (AI-generated personalized plans), the Treatment Engine (rules-based or AI-driven mapping of therapies to biomarkers), AI Consultations (conversational result interpretation), and Client Monitoring (compliance tracking with automated re-test and upsell triggers). A 6-8 hour certification program and dedicated account managers support practitioner onboarding.
PNOĒ's go-to-market is B2B, targeting functional medicine clinics, fitness and performance centers, longevity clinics, luxury hospitality, social wellness brands, and pulmonary/respiratory therapy practices. The company sells or leases its device directly to health professionals with 0% interest financing, and monetizes through the recurring PNOĒ GROW subscription (reports, expert access, certification, software tools). Practitioners charge end clients $125-$350 per metabolic test and reportedly generate $1,000-$5,000/month in recurring revenue, with many breaking even on just 1-2 clients per month. PNOĒ has raised approximately $10.3M across disclosed rounds from investors including Y Combinator, Fifty Years, Klinkert Investment Trust, Joyance Partners, Social Starts, and UpHonest Capital. The company serves 3,000+ experts worldwide, with named enterprise customers including Equinox, Four Seasons, Remedy Place, NuBioAge, and Restore Hyper Wellness.
Pnoe firmographics
Firmographics- Name
- Pnoe
- Legal name
- PNOĒ Inc.
- Website
- https://pnoe.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PNOĒ builds portable clinical-grade breath analysis devices and software that measure 23 metabolic biomarkers (VO2 max, RMR, biological age) for health professionals. Founded 2016, it serves 3,000+ practitioners across functional medicine, fitness, longevity, and hospitality segments.
- Ownership category
- akta.pro rank
Pnoe industry classification
Industry- Product category
- Metabolic Testing Equipment
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)
- akta.pro secondary industries
- Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate) (HLAHAOAB), Hydration, Nutrition & Metabolic Tracking Devices (Smart Bottles, Breath/Metabolic Analyzers) (CRACAQAI)
Keywords
Where Pnoe is headquartered
LocationHeadquarters
- HQ city
- Malden
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Pnoe business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Equipment Sales/Lease: PNOĒ sells or leases its metabolic analysis device to health and wellness professionals. Equipment can be purchased or leased with terms including 0 down, 0% interest, and 3-month deferral options.
- PNOĒ GROW Subscription: Monthly subscription package providing access to reports (Metabolic Blueprint, Biological Age Analysis, Precision Breathwork, Basic RMR/AMR), metabolic expert access, marketing materials, certification programs, consultation calls, and application access.
- Metabolic Testing Services: Practitioners charge clients $125-$350 for metabolic testing services including VO₂ max, RMR, and biological age analysis.
- Professional Services & Consultations: Revenue generated from personalized nutrition plans, training programs, and consultation services powered by PNOĒ data.
- Equipment Service & Maintenance: Service fees for equipment maintenance including O2 sensor replacement, battery replacement, and SD card changes. Fee of $2,500 for USA residents including additional costs; $600 for legacy users prior to May 1, 2022.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Equipment Purchase with Subscription |
| Unit Pricing | Pay-as-you-go | Metabolic Testing Services |
| Subscription | Monthly | 0% Financing Option |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Pnoe product offering
Product offeringCore offering
PNOĒ sells a portable, clinical-grade indirect-calorimetry breath analyzer (the PNOĒ Device) that measures 23 metabolic biomarkers including VO2 max, resting metabolic rate, fat and carbohydrate oxidation, and biological age. The device is paired with the PNOĒ Precision iOS app, a cloud-based Health Dashboard unifying 225+ biomarkers, an AI-powered nutrition and training builder, a Treatment Engine, and the PNOĒ GROW subscription bundle for health and wellness professionals.
Product overview
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. The core offering is the PNOĒ Device—a portable breath analysis system—paired with the PNOĒ Precision App (mobile interface for iOS) and PNOĒ Health Dashboard (cloud-based platform for 225+ biomarkers). Additional modules include the Treatment Planning/Builder for AI-generated personalized nutrition and training programs, the Treatment Engine for mapping therapies to biomarkers, Client Monitoring for real-time compliance tracking, and AI Consultations for always-on assistant support. The PNOĒ GROW subscription provides access to all technology, expert support, and educational resources. Together, these components form a unified ecosystem where breath analysis data flows from the device through the app and dashboard, enabling personalized programming, client tracking, and business growth tools for health and performance professionals.
Differentiator
Problem solved
Functional benefit
Products and services
- PNOĒ Device A portable, non-invasive breath analysis device that measures 23 metabolic biomarkers including VO2 max, resting metabolic rate (RMR), fat burn efficiency, carbohydrate oxidation, ventilatory efficiency, heart rate variability, and biological age in under 10 minutes. Sold or leased to health, fitness, and longevity professionals. Validated to match the accuracy of the COSMED Quark CPET gold standard.
- PNOĒ Precision App iOS mobile application that lets practitioners and their clients view PNOĒ test results, track progress over time, and access personalized health insights. Integrates with Apple Health and Google Fit to unify metabolic data with daily activity, sleep, and heart rate.
- PNOĒ Health Dashboard Cloud-based dashboard that aggregates PNOĒ breath analysis with wearables, blood tests, body scans, and other biometrics into a real-time view of 225+ biomarkers. Visualizes trends in VO2 max, RMR, HRV, cortisol, and substrate utilization, and generates advanced insights for practitioners.
- PNOĒ GROW Subscription Recurring subscription package that bundles PNOĒ reports (Metabolic Blueprint, Biological Age Analysis, Precision Breathwork, Basic RMR/AMR), metabolic expert access, marketing materials, certification programs, consultation calls, and application access. Designed as the ongoing software and services layer for practitioners who have purchased or leased a PNOĒ Device.
- PNOĒ Certification Program Self-paced professional certification course that trains health and wellness practitioners to interpret PNOĒ reports, apply metabolic science, and run best-practice testing. Typically bundled with the PNOĒ GROW subscription.
Quantifiable outcome
- Clients convert 15-40 leads per event into long-term clients
- +3 more outcomes
Companies that use Pnoe
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
Pnoe technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability5 records
Feature7 records
Pnoe partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- LumaticoreStrategic partnership announced at the 2025 Biohacking Conference combining PNOĒ's metabolic and VO₂max breath analysis platform with Lumati's Recharge Portal featuring five synergistic therapies. The alliance enables both companies to offer complementary services, share sales and marketing channels, and pursue future technological integration to deliver a unified, data-driven personalized wellness experience. A study conducted by PNOĒ using its metabolic analysis device showed that a single 15-minute Lumati session can reverse biological age by seven years.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Pnoe competitors and assessment
Company assessmentDirect peers
- COSMED: COSMED is the gold-standard manufacturer of cardiopulmonary exercise testing (CPET) and metabolic carts (Quark series) used in clinical and research settings. PNOĒ explicitly validates its device against the COSMED Quark CPET, making COSMED the most direct accuracy and use-case benchmark.
- Parvo Medics: Parvo Medics manufactures the TrueOne 2400 metabolic measurement system, a leading indirect calorimetry device used in research and clinical labs. It competes with PNOĒ in measuring VO2/VCO2 for metabolic and exercise testing applications.
- VO2 Master: VO2 Master produces portable, lower-cost VO2 max analyzers used by sports performance coaches and clinics. It is the closest portable alternative to PNOĒ, competing on portability and price in the same practitioner segment.
- MGC Diagnostics (now part of Cigniti / formerly Ultima Medical): MGC Diagnostics (and predecessors like MedGraphics) manufacture CPET and metabolic carts (e.g., Ultima CardiO2) used in hospitals and research. Direct competitor in clinical-grade VO2 max and metabolic measurement.
Broad incumbents
- Vyaire Medical: Vyaire Medical is a large incumbent in respiratory diagnostics and pulmonary function testing equipment. It addresses similar clinical customers (hospitals, pulmonary labs) with a much broader respiratory product portfolio than PNOĒ.
- WHOOP: WHOOP is a consumer wearable that surfaces VO2 max, HRV, and recovery metrics to athletes and biohackers. It overlaps with PNOĒ's downstream user base and could erode the value of consumer-tier metabolic insights, though it lacks clinical-grade indirect calorimetry.
- Oura: Oura Ring is a popular consumer wearable for sleep, HRV, and readiness metrics with growing presence in longevity and biohacking communities. Competes for the same end-user attention and discretionary wellness budget as PNOĒ's downstream customers.
Emerging players
- Levels: Levels sells continuous glucose monitors (CGM) paired with software to track metabolic health. It overlaps with PNOĒ in metabolic optimization and biohacking customers but uses a different measurement modality (glucose vs. breath).
- Function Health: Function Health offers comprehensive blood-based biomarker testing with a longevity positioning. It targets the same biohacking/longevity audience as PNOĒ but focuses on lab diagnostics rather than breath analysis.
- InsideTracker: InsideTracker provides blood biomarker analysis with personalized nutrition and longevity recommendations for consumers and performance-oriented users. It overlaps with PNOĒ in longevity/performance customers and AI-driven personalized programming.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Pnoe social profiles
Digital presencePnoe financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pnoe leadership team
Management profileNumber of profiles
Profiles3 records
Pnoe subsidiaries and ownership
Company hierarchySubsidiaries1 record
Pnoe funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pnoe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pnoe
What does Pnoe do?
PNOĒ sells a portable, clinical-grade indirect-calorimetry breath analyzer (the PNOĒ Device) that measures 23 metabolic biomarkers including VO2 max, resting metabolic rate, fat and carbohydrate oxidation, and biological age. The device is paired with the PNOĒ Precision iOS app, a cloud-based Health Dashboard unifying 225+ biomarkers, an AI-powered nutrition and training builder, a Treatment Engine, and the PNOĒ GROW subscription bundle for health and wellness professionals.
Is Pnoe a public or private company?
Pnoe is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pnoe founded?
Pnoe was founded in 2016. It employs 1 to 10 people.
Where is Pnoe based?
Pnoe is headquartered in Malden, United States, in the North America region.
How does Pnoe make money?
Five revenue lines are on record. Equipment Sales/Lease is the primary driver. The others are PNOĒ GROW Subscription, metabolic Testing Services, professional Services & Consultations and equipment Service & Maintenance.
Who are Pnoe's main competitors?
Direct peers on record are COSMED, Parvo Medics, VO2 Master and MGC Diagnostics (now part of Cigniti / formerly Ultima Medical). Broad incumbents are Vyaire Medical, WHOOP and Oura. Emerging players are Levels, Function Health and InsideTracker.
Does Pnoe have an API?
No public API is recorded for Pnoe.
What industry is Pnoe in?
Pnoe's product category is Metabolic Testing Equipment. Its primary akta.pro industry code is HLAHAGAH, Pulmonary Function Testing (PFT) & Spirometry Equipment, with a secondary code of HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry). Its NAICS code is 334516 and its SIC code is 3826.